Short- and medium-term outcomes of video-assisted thoracoscopic surgery versus thoracotomy for carinal lung resection combined with carina reconstruction in locally advanced non-small cell lung cancer patients.

BACKGROUND: The application of video-assisted thoracoscopic surgery (VATS) for complex carina surgeries in treating non-small cell lung cancer (NSCLC) patients with involved carina is controversial. This study compared short- and medium-term outcomes of VATS versus thoracotomy for carinal lung resection with carina reconstruction in treating locally advanced NSCLC, aiming to assess the potential benefit of VATS over thoracotomy for these patients. METHODS: A total of 37 consecutive NSCLC cases receiving VATS (n = 14) or thoracotomy (n = 23) for carinal lung resection with carina reconstruction from 2016 to 2021 were retrospectively identified. Baseline clinicopathological characteristics, perioperative outcomes, and survival profiles were investigated. RESULTS: Patients in the VATS and thoracotomy groups had comparable baseline clinicopathological characteristics (all p > 0.050). VATS decreased postoperative drainage volume compared with thoracotomy (1280 [1170-1510] vs. 1795 [1510-1905] mL, p = 0.012). Regarding surgical-related pains, VATS reduced numeric rating scale scores on the postoperative day 1 (4 [3, 4] vs. 5 [4, 5], p = 0.021) and day 2 (3 [3, 4] vs. 5 [3-5], p = 0.023) than thoracotomy. No difference was found between the VATS and thoracotomy groups in other perioperative outcomes, postoperative complications, and assessment of lymph nodes (LNs) and LN stations (all p > 0.050). Moreover, patients in the two groups had comparable 3-year disease-free survival (DFS), overall survival (OS), and recurrence and mortality patterns. Further subgroup and Cox hazards regression analyses also observed no difference in DFS or OS between the two groups. CONCLUSIONS: VATS reduced postoperative drainage volume and ameliorated surgical-related pain, and achieved comparable medium-term survival compared to thoracotomy for carinal lung resection with carina reconstruction in treating locally advanced NSCLC.

Supervivencia a mediano plazo de pacientes críticamente enfermos con función renal normal, lesión renal aguda y enfermedad renal crónica / Medium-term survival of critically ill patients with normal renal function, acute kidney injury and chronic kidney disease / Sobrevivência a médio prazo de pacientes criticamente doentes com função renal normal, lesão renal aguda e doença renal crônica

Resumen: Introducción: La falla renal es la tercera disfunción orgánica más frecuente en pacientes ingresados al hospital y la Unidad de Cuidados Intensivos; la supervivencia de pacientes críticamente enfermos con lesión renal aguda es aproximadamente 70%, pero los datos en pacientes críticamente enfermos con enfermedad renal crónica son escasos. Objetivo: Contrastar la supervivencia a mediano plazo de pacientes críticamente enfermos con función renal normal, lesión renal aguda y enfermedad renal crónica. Material y métodos: Se eligieron todos los pacientes ingresados de forma consecutiva a la Unidad de Cuidados Intensivos de enero 01 a diciembre 31 de 2018, se diagnosticó la función renal al ingreso, fueron seguidos a 90 días y se contrastó la supervivencia entre los tres grupos. Resultados: De los 355 pacientes para el análisis final, a 184 (51.8%) se les diagnosticó función renal normal, 96 (27.1%) lesión renal aguda y 75 (21.1%) enfermedad renal crónica al ingreso a la Unidad de Cuidados Intensivos. La edad fue mayor en los grupos de lesión renal aguda y enfermedad renal crónica que en el grupo de función renal normal (64.0 ± 17.6 y 67.8 ± 16.3 vs 56.7 ± 18.5 años, p = 0.000), el porcentaje de mujeres fue menor en el grupo de lesión renal aguda y enfermedad renal crónica que en el grupo de función renal normal (46/96 [47.9%] y 25/75 [47.6% vs 122//184 [63.3%], p = 0.001). La supervivencia fue menor en los grupos de lesión renal aguda y enfermedad renal crónica contrastada con el grupo de función renal normal (66/96 [68.75%] y 49/75 [65.33%] vs 150/184 [81.5%], Logrank test = 0.007). Conclusiones: La supervivencia a mediano plazo de pacientes críticamente enfermos con lesión renal aguda y enfermedad renal crónica al ingreso a la Unidad de Cuidados Intensivos es baja contrastada con el grupo de función renal normal.

Abstract: Introduction: Renal failure is the third most frequent organ dysfunction in patients admitted to the hospital and Intensive Care Unit; survival of critically ill patients with acute kidney injury is approximately 70%, but data in critically ill patients with chronic kidney disease are scarce. Objective: To contrast the medium-term survival of critically ill patients with normal renal function, acute kidney injury and chronic kidney disease. Material and methods: All patients consecutively admitted to the Intensive Care Unit from January 01 to December 31, 2018, were chosen, renal function was diagnosed on admission, they were followed up for 90 days and survival between the three groups was contrasted. Results: Of the 355 patients for the final analysis, 184 (51.8%) were diagnosed with normal renal function, 96 (27.1%) acute kidney injury, and 75 (21.1%) chronic kidney disease on admission to the Intensive Care Unit. Age was higher in the acute kidney injury and chronic kidney disease groups than in the normal renal function group (64.0 ± 17.6 and 67.8 ± 16.3 vs 56.7 ± 18.5 years, p = 0.000), the percentage of women was lower in the group acute kidney injury and chronic kidney disease than in the normal renal function group (46/96 [47.9%] y 25/75 [47.6% vs 122//184 [63.3%], p = 0.001). Survival was lower in the acute kidney injury and chronic kidney disease groups compared to the normal kidney function group (66/96 [68.75%] and 49/75 [65.33%] vs 150/184 [81.5%], Logrank test = 0.007). Conclusions: The medium-term survival of critically ill patients with acute kidney injury and chronic kidney disease on admission to the intensive care unit is low compared to the group with normal kidney function.

Resumo: Introdução: A insuficiência renal é a terceira disfunção orgânica mais frequente em pacientes internados no hospital e na Unidade de Terapia Intensiva; a sobrevivência de pacientes críticos com lesão renal aguda é de aproximadamente 70%, mas os dados em pacientes críticos com doença renal crônica são escassos. Objetivo: Compare a sobrevivência a médio prazo de pacientes críticos com função renal normal, lesão renal aguda e doença renal crônica. Material e métodos: Todos os pacientes admitidos consecutivamente na Unidade de Cuidados Intensivos de 1º de Janeiro a 31 de Dezembro de 2018 foram escolhidos, a função renal foi diagnosticada na admissão, foram acompanhados por 90 dias e a sobrevivência entre os 3 grupos foi contrastada. Resultados: Dos 355 pacientes para a análise final, 184 (51.8%) foram diagnosticados com função renal normal, 96 (27.1%) lesão renal aguda e 75 (21.1%) doença renal crônica na admissão na unidade de terapia intensiva. A idade foi maior nos grupos lesão renal aguda e doença renal crônica do que no grupo função renal normal (64.0 ± 17.6 e 67.8 ± 16.3 vs 56.7 ± 18.5 anos, p = 0.000), o percentual de mulheres foi menor no grupo agudo lesão renal e doença renal crônica do que no grupo com função renal normal (46/96 [47.9%] y 25/75 [47.6% vs 122//184 [63.3%], p = 0.001). A sobrevivência foi menor nos grupos de lesão renal aguda e doença renal crônica em comparação com o grupo de função renal normal (66/96 [68.75%] e 49/75 [65.33%] vs 150/184 [81.5%], teste Logrank = 0.007). Conclusões: A sobrevivência em médio prazo de pacientes críticos com lesão renal aguda e doença renal crônica na admissão na unidade de terapia intensiva é baixa em comparação com o grupo com função renal normal.

Medium term results following heart transplantation for end stage heart failure: A single center experience of 257 patients.

OBJECTIVE: End stage heart failure is a lethal disease with a dismal 5 year survival. Heart transplantation has proven to be a highly effective modality of treatment in appropriately selected group of such patients. This is a retrospective analysis of medium term outcomes of heart transplantation in the setting of a private health facility in India. The objective of this study was two fold. METHODS: The outcome of 257 heart transplants done at a single centre from October 2012 to October 2019 was analyzed. Patients with combined Heart and lung transplants and those whose complete medical records were unavailable were excluded from the study. Survival was tracked at 60 days, 90 days, one year and beyond for a maximum of 7 years. Preoperative patient risk profiles were characterized on the basis of INTERMACS category. RESULTS: There were 176 male and 81 female patients. The age range was from 8 months to 78 years with a mean of 32.9 years. Survival at 2 months was 87%, at 90 days was 83%, at one year was 81%, 2 years was 75%, at 3 years was 72% and at 5 years and beyond was 62% for the whole series. Strong predictors of 90 day mortality included INTERMACS category (odd's ratio 0.289, p = 0.000) and creatinine more than 1.5 mg/dl (odd's ratio 2.48, p = 0.056). Recipient pulmonary vascular resistance and donor organ ischemic times were not found to be statistically significant factors affecting outcome. Medium term survival was influenced by INTERMACS category (Hazard ratio > 3 for INTERMACS category 1 compared to INTERMACS 4 or 5, p < 0.0001) and creatinine > 1.5 mg/dl (Hazard ratio 2.15, p = 0.003). This effect of creatinine was related to the age of the recipient. Hazard ratio 1.4, p = 0.524 if age <30 and Hazard ratio 4.78, p = 0.006, if age was >50. CONCLUSION: Satisfactory medium term outcome is possible after heart transplantation even in resource constrained environment of a developing country.

Improved Survival of Computer-Assisted Unicompartmental Knee Arthroplasty: 252 Cases With a Minimum Follow-Up of 5 Years.

BACKGROUND: Unicompartmental knee arthroplasty (UKA) is an underutilized implant for medial tibiofemoral arthritis despite proven benefits in performance and reduced complications. This is likely related to registry recorded higher revision rates compared with total knee arthroplasty. It is our feeling that better component alignment resulting from the usage of computer-assisted surgery should improve longer-term functional results and survival of UKAs. METHODS: Between August 2003 and June 2007, 265 medial UKAs were performed in 264 consecutive patients using navigation. RESULTS: Eighty-eight women and 176 men with an average age of 51.7 (±4.63) years were assessed for function and survival over a follow-up period of 92.6 (63-120) months (7.7 years). The final survival rate over 5 years for this cohort was 97.6% at 5 years. CONCLUSION: We conclude that computer-assisted UKA, to treat medial tibiofemoral joint arthritis, produces 5-year survival rates that are comparable with total knee arthroplasty.